MainReads

Discover Books. Explore Knowledge.

Home » Medicine & Health » Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland.
📖
Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland.
Bainbridge J, Mealing S, Graham C, Jenal M, von Dombrowski N, Dymond A
Read Online (Full Reader) » Download PDF File » Open Original Publication Page »

Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland.

Author / Organization:
Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Appl Health Econ Health Policy.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland.
Author / Organization Bainbridge J, Mealing S, Graham C, Jenal M, von Dombrowski N, Dymond A
Subject & Discipline Appl Health Econ Health Policy
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-70264
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »